|
Market Cap (3-Jul) $356,619,552 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
IMM released this announcement to the ASX on 30 March 2022, 8:24. The announcement is marked as price sensitive, and is 4 page(s) in length and 330.5kb in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 1.372% short sold according to ASIC data. It was ranked the 155th most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| Efti with Keytruda shows encouraging activity in lung cancer | 30 March 2022, 8:24 |
| Immutep announces publication of ELCC 2022 abstract | 24 March 2022, 8:19 |
| Immutep to present Phase IIb breast cancer data at ESMO 2022 | 18 March 2022, 16:18 |
| Japanese patent granted for LAG-3 antibody LAG525 | 18 March 2022, 15:36 |
You must be logged in to post a reply.
